Journal of Clinical Microbiology and Infectious Diseases

Author Guidelines

Everything you need to know before submitting your manuscript to JCMID.

Contents

1. General Information 2. Pre-submission Checklist 3. AI Use & Disclosure Policy 4. Reporting Guidelines 5. Double-Blind Peer Review 6. Authorship (ICMJE) 7. Manuscript Format 8. Article Types & Structure 9. Tables & Figures 10. References (Vancouver) 11. Data Availability Statement
 

1. General Information

The Journal of Clinical Microbiology and Infectious Diseases (JCMID) welcomes original scientific contributions across the full spectrum of clinical microbiology and infectious diseases, including antimicrobial resistance (AMR), hospital-acquired infections (HAIs), tropical and parasitic diseases, virology, mycology, bacteriology, and infection-relevant immunology. The journal promotes evidence-based knowledge exchange among clinicians, microbiologists, and infectious disease researchers worldwide.

All manuscripts must be written in clear, scientifically precise English, following the guidelines in Scientific Style and Format (Council of Science Editors, 7th ed.) and the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals.

Originality requirement: Only manuscripts that have not been published previously (in print or electronically) and are not currently under consideration elsewhere will be accepted. Presentation of preliminary data at a scientific conference does not preclude publication, provided this is disclosed at submission.

Plagiarism policy: All submissions are screened with Turnitin. Manuscripts with a similarity index exceeding acceptable thresholds will be returned without review. Confirmed plagiarism results in an immediate rejection, a ban on future submissions, and notification of the authors' institutions and/or funding bodies.

Open Access: JCMID is a fully open-access journal. All articles are published under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence, allowing unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

2. Mandatory Pre-submission Checklist

Manuscripts missing any of the following items will be automatically rejected without review.

1

Ethical Clearance / IRB Approval

Provide the ethical clearance number and a copy of the approval letter from a recognized institutional review board (IRB/KEPK). For case reports and case series, also submit written informed consent from the patient or legal guardian (in English) and complete the ICMJE consent form. Studies involving animals must include IACUC approval.

2

Conflict of Interest Disclosure

All authors must disclose any financial, personal, or professional relationships that could influence the work. Download and complete the ICMJE Disclosure Form ↗

3

Funding Statement

Include a funding statement in the manuscript. If no funding was received, a statement of "no funding" must still be provided. Download the ICMJE Disclosure Form ↗

4

Author Contribution Statement (CRediT)

List the specific contribution of each author using the CRediT (Contributor Roles Taxonomy) framework (e.g., Conceptualization, Methodology, Investigation, Writing – Original Draft, Writing – Review & Editing, Supervision, Funding Acquisition). Download the Author Contribution Form ↗

5

Self-Citation / Self-Referencing Statement

Disclose all self-citations included in the manuscript. Excessive or inappropriate self-citation may result in rejection. Download the Self-Citation Statement Form ↗

6

Generative AI Disclosure Form

Mandatory for all submissions. Disclose whether any AI tools were used in manuscript preparation, regardless of the extent. A declaration of "no AI tools used" still requires the form. Download the AI Disclosure Form ↗

 

3. AI Use & Disclosure Policy

Policy Statement

JCMID adheres to the guidelines of COPE (Committee on Publication Ethics), ICMJE, and WAME on the use of artificial intelligence and AI-assisted technologies in scientific manuscripts. Transparency in the use of AI tools is a non-negotiable requirement of the publication process at JCMID.

What qualifies as AI use?

The use of any large language model (LLM), generative AI tool, or AI-assisted writing/coding platform — including but not limited to ChatGPT, Claude, Gemini, Copilot, Grammarly AI, DeepL, and similar tools — in any part of the manuscript preparation (writing, editing, translation, data analysis, coding, or figure generation) must be disclosed.

Permitted AI Uses

✓ Language editing and grammar correction

✓ Summarising or structuring existing content

✓ Literature search assistance

✓ Reference formatting and management

✓ Biostatistical code generation (with verification)

✓ Translation assistance (with professional review)

Strictly Not Permitted

✗ AI tools cannot be listed as co-authors

✗ AI-generated data, results, or laboratory findings

✗ AI-fabricated or hallucinated references

✗ AI-generated patient case details or clinical narratives

✗ Using AI to bypass ethical review responsibilities

✗ Undisclosed AI use in any part of the submission

Mandatory Disclosure Format

AI use must be disclosed in the Methods section and/or Acknowledgements, and must include: (1) the name and version of the AI tool, (2) the provider/developer, (3) a specific description of how it was used, and (4) a statement confirming that the output was reviewed and verified by the authors.

Example Disclosure Statement

"ChatGPT-4o (OpenAI, USA) was used to assist with English language editing of the manuscript. All AI-generated suggestions were critically reviewed and verified by the corresponding author. The AI tool was not used for data generation, analysis, or interpretation."

Consequences of non-disclosure: Failure to disclose AI use constitutes a breach of publication ethics under COPE guidelines. This may result in immediate rejection, retraction of published work, a permanent submission ban, and notification of affiliated institutions. The corresponding author bears full responsibility for the integrity of all AI-assisted content.

 

4. Reporting Guidelines

Authors must follow the relevant international reporting guideline for their study design. The appropriate completed checklist must be uploaded as a supplementary file at submission. JCMID uses reporting adherence as a quality criterion during editorial assessment.

CONSORT

Randomised Controlled Trials (RCTs). Includes CONSORT extension for cluster RCTs, non-inferiority trials, and pilot studies.

consort-statement.org ↗

STROBE

Observational studies: cohort, case-control, and cross-sectional designs.

strobe-statement.org ↗

PRISMA

Systematic reviews and meta-analyses. PRISMA-P for protocols; PRISMA-NMA for network meta-analyses.

prisma-statement.org ↗

CARE

Case reports. All clinical case reports must include the CARE checklist and a patient-friendly summary.

care-statement.org ↗

STARD

Diagnostic and prognostic accuracy studies, including microbiological diagnostic test evaluations.

equator-network.org ↗

ORION / IDSA

Infection prevention and control studies. IDSA/SHEA guidelines for AMR and HAI research.

equator-network.org ↗

Antimicrobial Susceptibility Testing (AST): All AST data must be reported following the most recent EUCAST or CLSI breakpoints. The breakpoint standard and version used must be explicitly stated in the Methods section. MIC values and susceptibility categories should be reported according to current EUCAST/CLSI interpretive criteria.

 

5. Double-Blind Peer Review Process

JCMID uses a double-blind peer review system: neither the reviewers' identities nor the authors' identities are disclosed to the other party at any stage of review.

1

Submission — Two Separate Files

File 1 — Title Page

Title, author names & affiliations, ORCID iDs, corresponding author contact (address, phone, email).

File 2 — Blinded Manuscript

Complete manuscript with no author names, affiliations, institution logos, or other identifying information.

Blinding checklist:

▸ Cite own prior work in third person: use "[Anonymous, year]" instead of "as we showed previously"

▸ Remove all institution or affiliation identifiers from figures, tables, and supplementary files

▸ Reference list entry: "[Anonymous year] Details withheld for double-blind review"

▸ Remove acknowledgements and funding statements

▸ Remove author names from file names and document metadata (Properties)

 
2

Initial Editorial Screening (1–2 weeks)

Editors assess: (a) relevance to JCMID scope, (b) English language quality, (c) completeness of all six mandatory pre-submission requirements, (d) compliance with the applicable reporting guideline, and (e) overall formatting. Manuscripts failing this check are returned without external review.

 
3

External Peer Review (4–6 weeks)

At least two independent reviewers with relevant expertise evaluate each manuscript. Authors have 14 days to submit a point-by-point response to reviewer comments. The reviewer then renders a final recommendation: Accept / Minor Revisions / Major Revisions / Reject.

 
4

Editorial Decision & Publication

Accepted manuscripts undergo final copyediting and proofreading. Authors must approve the final galley proof before conversion to PDF and HTML for online publication. Articles are assigned a DOI upon acceptance.

 

6. Authorship

All authors must satisfy ALL four ICMJE authorship criteria:

① Substantial contributions to conception/design, data collection, analysis, or interpretation.

② Drafting the work or critically revising it for important intellectual content.

③ Final approval of the version to be published.

④ Agreement to be accountable for all aspects of the work, including investigation and resolution of any accuracy or integrity issues.

Acknowledgements

Contributors who do not fulfil all authorship criteria (e.g., laboratory technicians, biostatisticians, medical writers) should be acknowledged in the Acknowledgements section with a description of their contribution.

Author List Changes

Changes to authorship — adding, removing, or reordering authors — are not permitted after submission. Verify the complete author list, spelling, affiliations, and ORCID iDs before submission.

Ghost / Guest Authorship

Ghost authorship (omitting a qualifying contributor) and guest/honorary authorship (including non-contributing individuals) are forms of authorship misconduct and will result in rejection or retraction.

 

7. Manuscript Format

Font

12pt Times New Roman, double-spaced, justified margins

File Format

Microsoft Word (.doc / .docx). PDF not accepted for initial submission.

Line Numbering

Continuous, from title to the end of the reference list

Margins & Document

2.5 cm (1 inch) all sides. No endnotes, headers, or footers in manuscript body.

Nomenclature

Pathogen names in italics (genus/species). Follow current ICTV and LPSN taxonomy.

Units

SI units throughout. MIC values in mg/L (µg/mL). Temperature in °C.

Title Page must include: a brief running title (max 60 characters), full names of all authors (first, middle initial, last), affiliations in English, ORCID iD for each author (strongly encouraged), corresponding author's full postal address, phone, and email. Word count, number of tables, and number of figures must also be declared.

 

8. Article Types & Structure

1. Original Research Articles

≤ 4,000 words ≤ 40 references

Required order: Title → Abstract (structured, ≤ 250 words: Background / Methods / Results / Conclusion) → Keywords (4–8) → Introduction → Materials & Methods → Results → Discussion → Conclusion → Data Availability Statement → Ethical Consideration → Funding → Conflict of Interest → Author Contributions → Acknowledgements → References → Tables → Figure Legends → Figures.

RCT registration: All Randomised Controlled Trials must be prospectively registered in an ICMJE-accepted registry (ClinicalTrials.gov or WHO ICTRP). The registration number must appear at the end of the abstract.

2. Review Articles / Systematic Reviews & Meta-analyses

≤ 6,000 words ≤ 100 references

Comprehensive critical synthesis of existing evidence on a topic relevant to clinical microbiology or infectious diseases. Systematic reviews must follow PRISMA guidelines and include a PRISMA flow diagram. Meta-analyses must include detailed statistical methods and forest plots where appropriate.

PROSPERO registration: Systematic reviews and meta-analyses must be prospectively registered in PROSPERO prior to data extraction. The registration identification number must be stated in the manuscript and at the end of the abstract.

3. Case Reports / Case Series

≤ 2,500 words ≤ 20 references

Structure: Abstract (unstructured, ≤ 150 words) → Introduction → Case Presentation → Diagnostic Workup → Management → Outcome → Discussion → Conclusion → References. Must follow the CARE checklist.

Must include: (a) written informed consent from patient/guardian (submit separately as supplementary file); (b) valid IRB approval or waiver number; (c) high-quality de-identified microbiological or clinical images (culture plates, microscopy, imaging) with descriptive captions.

4. Short Communications

≤ 1,500 words ≤ 20 references

Brief reports of focused original findings, emerging pathogen alerts, AMR surveillance data, or novel diagnostic/therapeutic observations with significant clinical impact. Unstructured abstract ≤ 150 words. May include up to 2 tables or figures.

5. Letters to the Editor

≤ 800 words ≤ 10 references

Scientific commentary, correction, or clinical observation responding to a recently published JCMID article, or brief reports of epidemiological significance. No abstract required. Max 1 table or figure. Max 5 authors.

 

9. Tables & Figures

Tables

▸ Double-spaced, placed on separate pages after the references

▸ Use Word's "Insert Table" function — no tabs or spaces to simulate columns

▸ Units in column headings only; define all acronyms in legend

▸ No shading; footnote symbols in order: *, †, ‡, §, ||, ¶, #

▸ AST tables must include the breakpoint standard and version (EUCAST/CLSI)

▸ Reproduced tables require written permission from original publisher

Figures

▸ High resolution: ≥ 300 dpi for photographs, ≥ 600 dpi for line art

▸ Accepted formats: TIFF, PNG, or EPS; embedded within the Word file for review

▸ Microscopy images must state magnification, stain type, and scale bar

▸ Patient faces and identifiable features must be masked or consent obtained

▸ Multi-panel figures labelled A, B, C; described in legend, not on the image

▸ Figure legends placed at end of manuscript text, not embedded in image files

 

10. References — Vancouver Style

References must follow the Vancouver Style, numbered sequentially in order of first citation in the text. All authors must be listed. Journal title abbreviations follow the NLM Index Medicus list; use full titles for journals not listed. A DOI must be included when available.

Format Examples

Journal article: Murray CJ, Ikuta KS, Sharara F, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–55. https://doi.org/10.1016/S0140-6736(21)02724-0

Guideline document: World Health Organization. Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report. Geneva: WHO; 2022.

Max references: 40 (Original Research) · 100 (Reviews)

DOI required when available (CrossRef DOI format)

Single-spaced with justified margins

Preprints permitted but must be clearly labelled as such

 

11. Data Availability Statement

All manuscripts must include a Data Availability Statement as a standalone section before the References. JCMID strongly encourages open data sharing to maximise research reproducibility and transparency.

Genomic & Sequence Data

All nucleotide sequences must be deposited in GenBank / NCBI / EMBL-EBI prior to submission. Accession numbers must be included in the manuscript.

Microarray / Proteomic Data

Microarray data must be deposited in GEO (Gene Expression Omnibus) or equivalent MIAME-compliant repository. Mass spectrometry data to ProteomeXchange.

Clinical / Epidemiological Data

De-identified datasets should be deposited in an open repository (e.g., Zenodo, Figshare, OSF) and a DOI provided. If data cannot be shared, the reason must be stated (e.g., patient confidentiality, institutional policy).

Example statement: "All raw sequence data have been deposited in the NCBI Sequence Read Archive (SRA) under accession number PRJNA######. The dataset used in this study is available from the corresponding author upon reasonable request."

⚠ Non-Compliance Warning

Accepted manuscripts that do not meet formatting requirements will be returned to authors for revision, which may delay publication. Manuscripts missing any mandatory pre-submission item will be automatically rejected without external review. Manuscripts containing undisclosed AI use, confirmed plagiarism, or fabricated data will be permanently rejected and reported to the authors' institutions.

Ready to Submit?

Ensure all mandatory pre-submission items are complete, the applicable reporting guideline checklist is uploaded, and the manuscript is fully blinded before submitting via the OJS portal.